Yasutomo Imai

Title: Yasutomo Imai: Innovator in Biopharmaceuticals

Introduction

Yasutomo Imai is a notable inventor based in Milwaukee, WI (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative polypeptides for medical applications. With a total of 2 patents, Imai's work focuses on addressing critical health issues such as psoriasis and autoimmune diseases.

Latest Patents

Imai's latest patents include the engineered CCL20 locked dimer polypeptide. This invention provides a CCL20 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of psoriasis and psoriatic arthritis. Another patent also revolves around the engineered CCL20 locked dimer polypeptide, emphasizing its use in treating psoriasis, inflammatory disorders, and autoimmune diseases.

Career Highlights

Yasutomo Imai is affiliated with the Medical College of Wisconsin, Inc., where he conducts his research and development work. His innovative approach to biopharmaceuticals has positioned him as a key figure in the medical research community.

Collaborations

Imai has collaborated with notable colleagues such as Brian Volkman and Anthony E Getschman. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Yasutomo Imai's contributions to biopharmaceuticals through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new treatments for complex health conditions.